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Purpose: Dysfunctional autophagy in the retinal pigment epithelium (RPE) has been 
implicated as a therapeutic target in age-related macular degeneration (AMD). To explore 
how RPE autophagy changes over the lifespan and in response to phagocytosis of 
photoreceptor outer segments (POS), we compared stem cell-derived RPE (hESC-RPE, 
iPS-RPE), human fetal RPE (hfRPE), the ARPE-19 cell line, and adult RPE (ad-RPE). 
Methods: RPE was cultured from 16-week human fetuses and cadaveric eyes. Stem cell-
derived RPE was prepared from human embryonic stem cells (hESC-RPE) and induced 
pluripotent stem cells (iPS-RPE). LC3 conversion (immunoblotting) and changes in 
autophagy-related gene expression (qRT2-PCR) were used to monitor autophagy. 
Relative maturity of RPE cultures was assessed using a panel of signature and maturation 
genes (qRT2-PCR). Autophagy was manipulated with an inhibitor, Spautin-1, and 
inducer, Rapamycin. iPS-RPE were challenged with porcine POS daily for up to 1 month, 
and monitored with confocal-immunomicroscopy.  The health of RPE cultures was 
monitored by the transepithelial electrical resistance (TER). 
Results: Autophagic flux (immunoblot) increased from stem cell to a peak in 78-year-old 
RPE, but was reduced in 91-year-old RPE. Spautin-1 inhibited autophagy only 
partially—the strongest effect was on ARPE-19 and 91-year-old ad-RPE.  qRT2-PCR 
revealed quantitative differences in the expression of autophagy- and maturation-related 
genes. In iPS-RPE, the expression level of most maturation genes was most similar to 
hfRPE. However, iPS-RPE and ad-RPE exhibited substantially higher levels of 
autophagy-related genes than hfRPE. Continuous feeding of POS to iPS-RPE for three 
weeks lowered TER to physiologic levels. In iPS-RPE, three-weeks of exposure to POS 
had little effect on autophagy or signature gene-expression, but did result in the 
accumulation of autofluorescent granules. Continuous feeding of POS to hfRPE for one 
week increased the expression of autophagy genes to levels observed in iPS- and ad-RPE. 
Conclusions: The characteristics of autophagy depended on the culture model: 
autophagy gene expression in iPS-RPE more closely resembled adult RPE than hfRPE. 
Partial inhibition by Spautin-1 suggests the presence of a non-canonical RPE autophagy 
pathway that is lost in old age. The accumulation of lipofuscin-like granules induced by 
POS indicates that complementary RPE cultures will be a valuable aid to explore targets 
for therapeutic agents for AMD.  
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INTRODUCTION 
Age-related Macular Degeneration !
Age-Related Macular Degeneration (AMD) is the leading cause of blindness in 
elderly populations of developed countries. In the United States alone, more than 9 
million people have AMD, of whom nearly 2 million individuals have advanced AMD. 
Due to a rapidly aging population, the prevalence of AMD is predicted to double by 2020 
[1]. AMD impairs central vision and adversely affects the ability to perform routine 
activities, such as reading, driving, using the phone, and recognizing faces [2]. 
Unfortunately, current therapies serve only to delay disease progression, not restore sight. 
AMD has a complex pathology and is divided into two main forms. In the dry 
form (85-90% of patients), central vision loss is progressive and slow, and is associated 
with macular drusen formation, retinal pigment epithelium (RPE) degeneration, and 
photoreceptor death [3]. Significant vision loss occurs in the advanced stage of dry AMD, 
aptly known as “geographic atrophy” for the confluent areas of RPE and photoreceptor 
degeneration seen on fundus exam. Substantial vision loss is also a hallmark of the wet 
(exudative) form of AMD, which affects 10-15% of patients [4]. The defining feature of 
wet AMD is choroidal neovascularization, which presents as rapidly progressive vision 
loss secondary to blood vessel leakage and macular edema [4]. Since wet AMD arises in 
a background of dry AMD, the latter is considered a risk factor for developing exudative 
AMD [5]. 
The etiology of AMD is multifactorial, arising through a combination of genetic, 
environmental, and behavioral factors [6]. As its name suggests, advancing age is the 
greatest risk factor associated with developing AMD. Studies of identical twins suggest 
that genetic factors account for 46%-71% of the variation in AMD severity, with a higher 
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heritability estimate at more advanced stages of disease [7]. Genome-wide association 
studies have been instrumental in identifying genetic variants predisposing to AMD [6]. 
In particular, studies have confirmed association of several common variants in genes 
related to the alternative complement cascade, such as Y402H in the CFH gene on 
chromosome 1 [8]. In addition to genetic factors, a number of lifestyle and environmental 
factors have been associated with AMD, including obesity, sunlight exposure, and diet 
[6]. Studies consistently demonstrate a strong positive association between smoking and 
development of AMD, perhaps due to oxidative stress and depletion of antioxidants [9]. 
The multifactorial etiology and complex pathology of AMD lend to the 
challenging task of developing effective therapies. Although there is currently no curative 
treatment for AMD, the development of intravitreal anti-vascular endothelial growth 
factor (VEGF) therapy in the past decade has significantly improved outcomes for wet 
AMD, with 40% of patients gaining vision [10]. There remains no effective treatment for 
dry AMD, setting the stage for a major public health problem as the population ages.  
 
Figure 1. Age-Related Macular 
Degeneration (AMD) 
Pathogenesis. Comparing dry and 
wet forms of AMD. In the dry form 
(left), extracellular aggregates 
known as drusen accumulate under 
the retina. Drusen are seen as 
yellow lipid-like deposits on fundus 
exam. In the wet form (right), 
choroidal neovascularization 
disrupts the neural retina, leading to 
fluid leakage, hemorrhage, and 
macular edema. (Adapted from 
http://www.hopkinsmedicine.org/wi
lmer/conditions/AMDretina-
detail.html).  
!! 3!
Retinal Pigment Epithelium 
 
 
 
Figure 2. Summary of 
Retinal Pigment Epithelium 
(RPE) Functions. PEDF, 
pigment epithelium-derived 
growth factor; VEGF, 
vascular epithelium growth 
factor; Epithel, epithelium. 
(Adapted from: Strauss, Olaf. 
The Retinal Pigment 
Epithelium in Visual 
Function. Physiol Rev. 
2005;85:845–881) !
The RPE is a monolayer of polarized epithelial cells situated between the 
photoreceptor layer and Bruch’s membrane, overlying the choriocapillaris. The RPE 
forms the outer blood-retinal barrier, and plays a vital role in neuroretinal survival. 
Macular RPE degeneration is a hallmark of AMD [4]. Figure 2 highlights RPE functions 
crucial to retinal well-being, including vitamin A metabolism and maintenance of the 
visual cycle, stray light absorption, and nutrient and waste exchange. Particularly relevant 
to this project, the RPE is responsible for phagocytosis and degradation of the distal tips 
(known as discs) of photoreceptor outer segments (POS) that are shed from the neural 
retina on a daily basis. Young and colleagues were the first group to illustrate this daily 
cycle of POS disc shedding, RPE disc phagocytosis, and disc renewal in the 1960s [11-
13]. In the decades since, studies have identified three distinct phases of the RPE 
phagocytic process: 1) recognition/binding; 2) internalization; and 3) digestion [14]. 
Remarkably, in all vertebrate species tested, POS shedding and phagocytosis follow a 
diurnal rhythm [15]. Each RPE cell serves 30-40 photoreceptors, and has the highest 
phagocytic activity of any cell in the body [14]. Impaired RPE phagocytosis plays a role 
in several retinal degenerative diseases, including forms of retinitis pigmentosa [16, 17] 
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Given that RPE cells are post-mitotic and nonrenewable, these tasks place 
extraordinary metabolic demands on the RPE mitochondria and endolysosomal system 
over the lifetime of an individual [18]. The RPE is especially susceptible to high levels of 
reactive oxygen species (ROS) secondary to constant light exposure and phagocytosis of 
the lipid-rich POS. Over time, the resulting chronic oxidative stress and low-level 
inflammation contribute to RPE senescence [19, 20]. Oxidative stress leads to impaired 
protein degradation and the accumulation of undegraded material known as lipofuscin in 
lysosomes [19, 21]. Lipofuscin inhibits mitochondrial respiration and promotes protein 
misfolding [21]. Additionally, lipid peroxidation products have been shown to prevent 
lysosomal degradation of POS. Krohne et al. demonstrated that lipid peroxidation 
modification of POS leads to apical-to-basolateral transcytosis and extrusion of 
undegraded POS proteins in vitro [22]. The extruded material contributes to lipid-rich 
deposits known as drusen, a characteristic finding in AMD [22].  
 
Autophagy—The Players !
Unlike most other post-mitotic cells, RPE cells are not regularly replaced from 
resident stem cells. During its long life, the RPE relies on cellular processes to degrade 
and recycle senescent intracellular materials. In eukaryotic cells, autophagy is a chief 
intracellular method of disposing of proteins and organelles via lysosomal degradation. 
Unique to the autophagic pathway is the ability to recycle degraded components to use as 
building blocks for functional intracellular structures [23].   
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Autophagy is activated in situations of cellular stress, such as starvation, 
inflammation, and exposure to oxidative species [20, 24]. Autophagy also plays a role in 
cellular development, differentiation, and aging [25]. Clearance via autophagy occurs 
through three different methods—macroautophagy, microautophagy, and chaperone-
mediate autophagy. Macroautophagy involves lysosomal degradation of cytoplasmic 
organelles and proteins that are delivered to the lysosome via an autophagosomal vesicle. 
In microautophagy, the lysosomal membrane engulfs cytoplasmic contents without the 
assistance of an autophagosome. Lastly, chaperone-mediate autophagy involves cellular 
chaperones that aid in lysosomal uptake of particular proteins [24]. Figure 3 illustrates the 
steps of macroautophagy, the predominant method for clearing large protein aggregates 
and damaged organelles: an autophagosome engulfs misfolded proteins, damaged 
organelles, and phagosomes, and then fuses with a lysosome. Since autophagy is a 
relatively conserved pathway, initial molecular and genetic studies were conducted in 
nonmammalian systems, namely yeast [26]. Genetic studies in yeast led to the 
identification of the autophagy-related (ATG) genes, of which there are nearly 30 [27]. 
The molecular pathways involved in autophagy are well-reviewed, and 
immunofluorescent and polymerase chain reaction (PCR) arrays to study autophagy are 
commercially available. Previous research has largely focused on the canonical 
autophagy pathway (Figure 3), which involves the formation of a double-membraned 
autophagosome around damaged organelles or protein aggregates. In the canonical 
pathway, autophagosomes emanate from the phagophore, which can arise from different 
membranes. 
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Figure 3. Canonical Autophagy Pathway. Activated mTOR (Akt and MAPK signaling) 
suppresses autophagy, and suppression of mTOR (Rapamycin, AMPK and p53 signaling) 
promotes it. Three related serine/threonine kinases, UNC-51-like kinase -1, -2, and -3 
(ULK1, ULK2, UKL3) act downstream of the mTOR complex. Class III PI3K complex is 
required for the induction of canonical autophagy. The Atg genes control the phagophore and 
autophagosome formation through Atg12-Atg5 and LC3-II (Atg8-II) complexes, 
respectively. LC3/Atg8 is cleaved at its C terminus by Atg4 protease to generate the 
cytosolic LC3-I. LC3-I is conjugated to phosphatidylethanolamine (PE) in an ubiquitin-like 
reaction that requires Atg7 and Atg3. The lipidated form of LC3, known as LC3-II, is 
attached to the autophagosome membrane. (Illustration reproduced courtesy of Cell 
Signaling Technology, Inc. www.cellsignal.com). 
 
Autophagy—The Modulators !
Autophagosome formation is induced by Class III phosphoinositide-3-kinase (PI-
3K), Beclin-1 (the mammalian ortholog of yeast Atg 6), and two ubiquitin-like 
conjugation systems (the Atg12-5 and Atg8 systems) [28]. The Atg12-Atg5 conjugation 
system promotes elongation and closure of the autophagosome, and is necessary to 
complete the second conjugation system, light chain 3 (LC3; Atg8 in yeast). LC3-I is a 
protein that is converted to its lipidated form, LC3-II, through conjugation with 
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phosphatidylethanolamine. LC3-I to LC3-II conversion occurs upon association with the 
autophagosome-lysosome fusion product [29]. This is a critical step in the completion of 
autophagy, as it is now recognized that an increase in autophagosome number by itself 
does not correlate with increased autophagic activity (also referred to as autophagic flux). 
Accordingly, monitoring LC3-I to LC3-II conversion is a more reliable way to assess 
autophagic flux, and there are commercially available LC3-II assays to do just that. 
Beclin-1 plays an important role in stimulating autophagy, thus the canonical 
autophagy pathway is often referred to as the “Beclin-dependent” pathway. The rate-
limiting PI-3K/Beclin-1 complex is also a useful target for pharmacological or small 
molecule inhibitors of autophagy, such as Spautin-1 (SP-1) and 3-methyladenine (3-MA) 
[30]. Upstream of Beclin-1 is another key autophagy modulator, the mammalian target of 
Rapamycin (mTOR), which negatively regulates autophagy [31]. Rapamycin (also 
known as sirolimus) is a natural product that inhibits the kinase activity of mTOR, and 
has been shown to induce autophagy in vivo and in vitro [32]. Studies have shown that 
Rapamycin has neuroprotective effects, making it a potential therapeutic agent for 
neurodegenerative disorders whose pathogenesis involves decreased or impaired 
autophagy, such as Alzheimer’s disease and Parkinson’s disease [33, 34].  
In addition to the canonical, Beclin1-dependent autophagy pathway, more recent 
studies point to the existence of a non-canonical (i.e., Beclin1-independent) autophagy 
pathway. In 2007, Zhu and colleagues described stimulation of a Beclin1-independent 
autophagic pathway in a human neuroblastoma cell line (SH-SY5Y) by the neurotoxin 1-
methyl-4-phenylpyridinium (MPP+) [35]. Beclin1-independent autophagy has been 
shown to play a role in differentiation [36], bacterial toxin uptake [37], and cortical 
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neuron death [38]. Interestingly, studies suggest that non-canonical autophagy can escape 
mTOR inhibition, indicating that there is also an alternative upstream regulator of 
autophagy [39].   
In summary, genetic and molecular studies in yeast have yielded an understanding 
of the autophagy-related genes (and their products) involved in the mammalian canonical 
macroautophagy pathway. The canonical pathway is Beclin1-dependent, and can be 
inhibited at the PI-3K/Beclin-1 complex (e.g., with SP-1, 3-MA). Rapamycin inhibits 
mTOR (a negative regulator of autophagy), and is useful in stimulation of canonical 
autophagy. Over the past decade, evidence has grown for the existence of an alternative, 
non-canonical autophagy pathway that is Beclin1-independent. In contrast to canonical 
autophagy, non-canonical autophagosome formation does not require hierarchical 
intervention of all of the ATG proteins [29]. Further, non-canonical autophagy can be 
mTOR-independent, in which case Rapamycin would not have a significant stimulatory 
effect on autophagic flux.  
 
Autophagy in AMD !
If autophagy is impaired or overwhelmed, cells accumulate debris, protein 
aggregates, and autophagosomes [40]. Dysfunctional RPE autophagy is implicated in the 
pathogenesis of AMD, although the exact disease mechanisms are not clear [41, 42]. 
Previous work from Vittal et al. demonstrated a decline in RPE autophagic efficiency 
associated with both advanced age (via chronic oxidative stress) and later stages of AMD 
[43]. As illustrated in Figure 4, impaired autophagy in the RPE (here, due to failure of 
autophagosome-lysosome fusion), leads to accumulation of undegraded material, 
!! 9!
lipofuscin formation, and eventual extrusion of autophagosomes from the basolateral side 
of the RPE cell to form drusen [22].  
 
Figure 4. Impaired RPE Autophagy. Autophagy functions to dispose of proteins and 
organelles (e.g., mitochondria) in an intracellular process that involves autophagosome-
lysosomal fusion. Age and oxidative damage contribute to damage of such structures. In the 
healthy cell, autophagic vesicles engulf damaged structures in phagophores to form 
autophagosomes, which fuse with lysosomes Phagocytosis of POS is known to interact with 
autophagy pathway, but the exact point of entry has not been determined. Here, two proposed 
points of POS entry are shown: 1) at the phagophore or 2) at the autophagosome. Within the 
fused autophagosome-lysosome vesicle, damaged structures are degraded and various 
components are recycled to rebuild functional intracellular structures. In the diseased cell (e.g., 
RPE in AMD), autophagy can be disrupted at multiple points (left). Impaired fusion of the 
autophagosome with the lysosome (step 3), lysosomal enzyme dysfunction, and phagocytic 
dysfunction can all result in the build-up of damaged intracellular material. This damaged 
material is eventually extruded from the basolateral side of the RPE, contributing to drusen 
formation and the thickened Bruch’s membrane that are hallmarks of AMD (right).    
 
As mentioned, besides autophagy, the RPE is responsible for phagocytosis of rod 
and cone outer segments (POS). RPE apical microvilli envelop the tips of rod and cone 
photoreceptors (Figure 4, right). The outer segment appears to be a stack of coins.  These 
“coins” are disc membranes that are stimulated by light to initiate a signaling cascade. 
Each 24-hour cycle, new discs are added to the base of the segment and an equal number 
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are shed from the tip. As post-mitotic cells, RPE must last a person’s lifetime to ensure 
both effective phagocytosis and lysosomal degradation of POS and recycling of visual 
cycle components. [14].  
Although the connection between RPE phagocytosis and autophagy is well-
established, the exact point where these two intracellular pathways intersect is less certain 
[44]. Evidence suggests that over time, aging RPE cells develop a phagocytic overload, 
ultimately burdening autophagic capacity and impairing normal autophagic function.    
Impaired ability of RPE autophagy to degrade phagocytized discs in lysosomes and 
recycle visual opsin components results in accumulation of lipofuscin, subretinal drusen 
formation, and development of AMD with central vision loss [18, 22]. Figure 4 illustrates 
two proposed points of entry for phagocytized POS into the autophagy pathway: 1) at the 
single membrane phagophore formation step, or 2) at the double membrane 
autophagosome formation step. Therefore, monitoring RPE phagocytosis and its 
downstream relation to the autophagy pathway and lysosomal degradation systems can 
provide insight into the pathogenesis of AMD, and identify potential therapeutic targets. 
 
Available RPE Culture Models for Study  !
The best physiological model of normal, healthy RPE is derived from fetal tissues 
[45]. Human fetal RPE (hfRPE) represent a relatively “young” RPE phenotype, and is the 
preferred culture model for studying normal RPE differentiation and maturation. Fetal 
RPE is also useful as a model to study disease development. For instance, by 
manipulating hfRPE autophagy, one can study the role of autophagy-related RPE 
dysfunction in AMD pathogenesis. However, there are significant controversies and 
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challenges regarding the use of hfRPE. Firstly, there are regulatory concerns. Secondly, 
the availability of hfRPE is insufficient to provide adequate numbers for high throughput 
screening of pathogenic processes and pharmacological options. Furthermore, there is 
inherent variability in hfRPE, requiring an assessment of each source’s functional 
capabilities [45]. Thus, developing alternative RPE culture model systems is both 
valuable and practical. 
Besides hfRPE, human embryonic stem cell-derived RPE (hESC-RPE) is another 
in vitro model that represents a healthy, “immature” RPE cell. Rizzolo and colleagues 
demonstrated that RPE derived from pluripotent ESCs is comparable to hfRPE in regards 
to barrier function and gene expression [45]. The Rizzolo lab has also optimized cell 
culture techniques to maintain native RPE features, for instance using serum free medium 
(SFM-1) to achieve in vivo-like transepithelial resistance (TER) levels in hfRPE and 
hESC-RPE [46, 47]. In these conditions, hESC-RPE is functionally more mature than in 
differentiation medium, but still less mature than hfRPE. In addition to its utility for in 
vitro studies, hESC-RPE has a potential role in therapeutic transplantation in diseases of 
RPE and neural retina degeneration. In October 2014, Robert Lanza, Steven Schwartz, 
and colleagues reported an update on two prospective phase I/II trials of subretinal 
transplantation of hESC-derived RPE injected in patients with dry AMD or Stargardt’s 
macular dystrophy [48]. Transplanted patients were followed for a median of 22 months, 
and results demonstrated a favorable safety profile, improvement in vision in almost half 
the treated patients, and increased vision-related quality-of-life [48]. However, although 
hESC-RPE is not associated with as many obstacles as hfRPE, widespread use is limited 
!! 12!
by availability, and ethical and regulatory concerns. Thus, alternative RPE models are 
desirable in the long-term.   
These concerns may be addressed by a promising new source of RPE cells, 
induced pluripotent stem cell-derived RPE (iPS-RPE). In 2006, a landmark paper from 
Kazutoshi Takahashi and Shinya Yamanaka reported the generation of ‘induced’ 
pluripotent stem (iPS) cells from mouse somatic cells by retroviral transduction of four 
transcription factors, Oct4, Sox2, Klf4, and c-Myc [49]. The next year, similar methods 
were used to generate human iPS cells from human tissues, revealing a novel way to 
study and treat disease using disease- and patient-specific iPS cells [50, 51]. Several 
groups have since demonstrated successful generation of human iPS-derived RPE from 
fibroblasts, T lymphocytes, and even human RPE [52-55]. Studies have shown that iPS-
RPE fulfill the criteria used to evaluate stem cell-derived RPE, including 1) hexagonal 
cell morphology formation, 2) appearance of pigmentation, 3) apical/basal polarity, and 
4) performs vital RPE functions such as phagocytosis of POS, formation of tight 
junctions, and secretion of growth factors [56, 57]. Additionally, concerns regarding iPS-
RPE retaining memory of their former cell type are being addressed by strategies where 
iPS cells are derived from ocular tissues, including human RPE [55, 58]. For retinal 
degenerative diseases such as AMD, iPS-derived RPE has the potential to revolutionize 
treatment and disease outcome via graft transplantation. Furthermore, and particularly 
relevant to this project, iPS-RPE cells provide a new platform to study and model disease 
in vitro without the ethical and availability concerns affecting hfRPE or hESC-RPE. 
For models of aged RPE, there are adult cadaveric eyes and the ARPE-19 cell 
line. Adult donor RPE tissue is an ideal culture model for translational research projects, 
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particularly those investigating degenerative diseases of the aging RPE and neural retina. 
Adult RPE cells from aged donor eyes have been shown to display decreased autophagic 
and phagocytic capacity. In one study, Schütt et al. induced aging via oxidative stress in 
donor RPE, and found a three-fold decrease in autophagy rates and a reduction in 
phagocytic capacity in these aged cells [59]. Mirroring the challenges of acquiring 
hfRPE, adult donor RPE is not available in adequate quantities for high throughput drug 
screening, although there a number of Eye Banks that have been established to help 
address this issue [60]. Adult RPE also has inherent differences between donor tissues, 
which is a possible limitation because experimental results are not necessarily 
generalizable. Additionally, adult RPE has proven difficult to grow in culture due to a 
tendency to undergo epithelial to mesenchymal transition (EMT). Recently, Blenkinsop 
and colleagues reported successful culture and maintenance of functional RPE 
monolayers by isolating intact RPE “sheets” from the adult human eye [61]. The resulting 
adult RPE cultures demonstrated morphological, phenotypic, and functional 
characteristics similar to native RPE [61]. This optimized protocol will help to 
standardize adult donor RPE culture, the value of which cannot be understated given the 
utility of adult RPE cultures for disease studies and as a cell source for transplantation 
therapy. 
Another cell line widely used to study AMD is ARPE-19. First described by Dunn 
et al. in 1996, ARPE-19 is an immortalized, spontaneously-arising cell line from a 19-
year-old male human donor [62]. ARPE-19 is a line with normal karyology that forms 
polarized epithelial monolayers on filter supports. Morphologically, ARPE-19 cells 
demonstrate characteristics akin to those of differentiated RPE cells, namely basolateral 
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infoldings, apical microvilli, and polarized distribution of cellular organelles [62].  
However, with passage in culture, ARPE-19 has become increasingly sensitive to culture 
conditions and is losing its original phenotype, leading to difficulty replicating some 
characteristics of differentiation, such as pigmentation and RPE65 expression [63]. To 
help counter this problem, studies in Dr. Lawrence Rizzolo’s laboratory and others have 
found low or no serum media that preserves the original phenotype [64]. Differentiated 
ARPE-19 phagocytizes POS more efficiently than hfRPE or iPS-RPE [65]. This 
observation raises the question of whether ARPE-19 is more mature than hfRPE or stem 
cell-derived RPE. In a comparison of in vitro RPE models, Ablonczy and colleagues 
found that properties of hfRPE more closely resembled those of a functionally normal 
RPE in vivo, whereas ARPE-19 cells resembled an aged RPE [66]. In particular, ARPE-
19 hypersensitivity to VEGF, loss of pigmentation, and weaker tight junctions reflect 
pathologic conditions or those of an aged eye [66]. Luo et al. reported ARPE-19 cells had 
low TER in culture, suggesting impaired barrier function. Attempts to subclone cells 
from ARPE-19 were unsuccessful because the clones quickly senesced [64]. Thus, 
ARPE-19 may be an appropriate in vitro model of diseased or aged RPE, and not 
representative of the nondiseased 19-year-old eye from which it was isolated. 
Previous Work !
The discussed study was conducted under the mentorship of Lawrence Rizzolo, 
PhD, and Ron Adelman, MD. The Rizzolo/Adelman laboratory has demonstrated their 
facility with the required techniques [46].  Recently, the lab used RNA-sequencing to 
quantify and compare the transcriptomes of hfRPE and RPE derived from two hESC cell 
lines, and used electrophysiology to examine these RPE models’ functionality as the 
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blood-retinal barrier [47]. Currently, the Rizzolo/Adelman lab is investigating whether 
co-culture with the retina induces the maturation of RPE. Additionally, in preliminary 
investigations of autophagy, the lab’s mRNA microarray expression data suggested 
differences among the RPE cultures for the autophagy pathways. This project aimed to 
confirm these preliminary data with real-time quantitative reverse transcription PCR 
(qRT2-PCR). Furthermore, the lab previously found that autophagy could be manipulated 
pharmacologically in two RPE culture models, hfRPE and ARPE19, with the use of 
pharmacological agents (Fig. 5-7).  
 
  
 
Figure 5. Autophagy Stimulation. 
Rapamycin (an mTOR inhibitor) increases 
autophagic flux in hfRPE. Association of LC3-
I with autophagosomes results in its conversion 
to LC3-II. The increase in the ratio of LC3-
II:LC3-I caused by rapamycin indicates that 
mTOR is a negative regulator of autophagy. 
Figure 6. Autophagy Inhibition. Spautin-1 
(SP-1) inhibits autophagy through its effects 
on Beclin-1 in ARPE-19. This is illustrated 
here by a decreased LC3-II:LC3-I ratio with 
increasing doses of Spautin-1.   
 
Figure 7. GFP-LC3 Immunofluorescence. 
SP-1 inhibits Beclin-1, and prevents the 
association of LC3 with autophagosomes in 
hfRPE. Normally, the lipidated form of LC3 
(LC3-II) associates with autophagosomes, 
which then fuse with lysosomes. Lysosomes 
were inhibited with Chloroquine to prevent 
the degradation of LC3-II. In SP-1 treated 
cells, LC3 accumulation in vesicles (green 
puncta) is diminished, and the pool of MITF 
shifts from nuclei to the cytoplasm. Blue, 
nuclei; Red, MITF; Green, LC3. 
LC3 II 
LC3 I 
Tubulin 
CTL 50nM 250nM 1000nM 
(Spautin-1) 
Merge LC3 
SP(-) 
SP(+) 
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PURPOSE AND AIMS !
Dysfunctional autophagy in the RPE has been implicated as a potential 
therapeutic target in AMD, although the exact mechanism of disease is unclear [4, 5]. A 
potential contributing factor is phagocytic overload from daily RPE phagocytosis of POS, 
which are shed from the overlying neural retina. The post-mitotic RPE is then responsible 
for lysosomal degradation of POS in an autophagy-related process. Over time, autophagic 
capacity of the RPE is overwhelmed by this phagocytic burden, leading to accumulation 
of vesicles, lysosomal dysfunction, and basolateral extrusion of undegraded material from 
the degenerating RPE, seen clinically as drusen. We hypothesize that, since the RPE lasts 
the lifetime of an individual, available RPE culture models can be considered along a 
spectrum of phenotypic “age” in terms of autophagic function (Figure 8). From fetal life 
on, RPE autophagic capacity increases and plateaus as needed to compensate for acute 
oxidative stress and phagocytized POS. In old age, however, autophagic capacity 
becomes impaired and declines. On one extreme of this spectrum lie hfRPE, hESC-
derived RPE, and presumably iPS-derived RPE, which represent “immature” RPE. As 
immature, stem cell-derived culture models, one can argue that these RPE lines may not 
be at the stage of development where autophagy processes have reached maturity. On the 
other end of the spectrum lies adult donor tissue RPE. Previous work demonstrates 
decreased autophagic function in this “aged” human tissue RPE. It is unclear where 
ARPE-19 lies along the phenotypic age continuum. Although studies have shown it to be 
superior in terms of POS phagocytosis, ARPE-19 has lost elements of normal RPE, and 
may better represent an aged or diseased RPE phenotype (Figure 8).  
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Characterizing phenotypic “age” of RPE cultures based on autophagic capacity 
can help establish a human culture model for studying AMD pathogenesis and screening 
pharmacological agents. I propose that there will be a difference in baseline autophagic 
flux and autophagy-related gene expression between available RPE culture models based 
on phenotypic age. Secondly, I predict that autophagic capacity can be manipulated to 
alter RPE culture age (for example, by feeding immature RPE cells POS, or by 
introducing new genes with a viral vector). Ultimately, these studies can help identify key 
genes or steps in the autophagic pathway as potential therapeutic targets for AMD. 
 
Aim 1 
Do differences in autophagy and maturation profiles of available RPE 
cultures help to characterize phenotypic age and explore how autophagy changes 
over the lifespan? For hfRPE, hESC-derived RPE, iPS-RPE, adult RPE, and ARPE-19 
cell lines, relative RPE maturation can be assessed by performing real time quantitative 
Figure 8. Phenotypic Age of Autophagy Pathway. Since the RPE lasts the lifetime of an 
individual, RPE cultures can be placed along a phenotypic age spectrum based on autophagic 
capacity. From fetal life on, RPE autophagic capacity increases and plateaus, until it is 
impaired in old age. We can manipulate this age spectrum to increase or decrease autophagy in 
various culture models (for example, by feeding immature RPE cells POS, or by introducing 
new genes with a viral vector). Characterizing phenotypic age of RPE cultures based on 
autophagic capacity can help establish a human culture model for studying AMD. (iPS-RPE: 
induced pluripotent stem cell-derived RPE; hfRPE: human fetal RPE; hESC-RPE: human 
embryonic stem cell-derived RPE)    
iPS-RPE? 
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PCR using a panel of RPE signature and maturation-related genes [47]. Custom 
autophagy-specific PCR arrays allow quantification of autophagy-related gene 
expression. Biochemical and cellular assays help to establish baseline autophagic flux.  
Aim 2 
Do modulators of autophagy alter phenotypic age and autophagic flux of 
different RPE cultures? Having established baseline characteristics, similar assays can 
be used to compare RPE cultures after treatment with an autophagy inhibitor (SP-1), 
inducer (Rapamycin), and POS feeds.  
METHODS 
  
Cell Culture 
Overview 
RPE was cultured from 16-week fetuses and cadaveric human eyes (ages 48-91). 
Human embryonic stem cell-derived RPE was prepared from human embryonic stem 
cells (hESC-RPE) at the Yale Stem Cell Center. Induced pluripotent stem cell-derived 
RPE were prepared from induced pluripotent stem cells (iPS-RPE) of adult human RPE 
origin at a collaborating facility, The Neural Stem Cell Institute (NSCI; Rensselaer, NY). 
Adult donor RPE were also prepared at NSCI, as outlined in the group’s published 
protocol [61]. Adult donor RPE (adRPE) and iPS-RPE were obtained or generously 
gifted from the NSCI. The RPE cell lines were maintained in culture media that promotes 
their differentiation. Prior to their use in experiments, hfRPE, hESC-RPE, and iPS-RPE 
were each adapted to a serum-free medium, SFM-1 [46]. ARPE-19 and adRPE were 
maintained in low-serum media [64]. TER, signature RPE gene expression, and cell 
morphology were monitored as markers for the health of RPE cultures. 
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Human fetal RPE (hfRPE) 
The research adhered to the tenets of the Declaration of Helsinki and the 
guidelines of the NIH Institutional Review Board. The secondary cultures of human fetal 
RPE cells were prepared from 16-week fetuses, and supplied by the laboratory of 
Sheldon Miller (National Eye Institute, Bethesda, MD). The hfRPE cells were trypsinized 
in 0.25% trypsin-EDTA for 10 minutes and this trypsinization was repeated three times. 
The cells were then resuspended in 15% serum-containing hfRPE cell culture medium. 
The suspensions were centrifuged for 10 minutes at 500 rpm. The serum culture medium 
consisted of MEM α-modified medium (Sigma-Aldrich, St. Louis, MO), fetal bovine 
serum (Atlanta Biologicals, Norcross, GA), N1 supplement (1:100 mL/mL; Sigma-
Aldrich), glutamine-penicillin-streptomycin (1:100 mL/mL; Sigma-Aldrich), 25 µg/mL 
nystatin, nonessential amino acid solution (1:100 mL/mL; Sigma-Aldrich), and 
hydrocortisone (20 µg/L), taurine (250 mg/L), and triiodo-thyronin (0.013 µg/L). Cells 
were seeded onto clear cell culture inserts at 1.3 × 105 per well (12-mm diameter inserts, 
0.4-µm pores, polyester membranes; Transwell; Corning Costar, Corning, NY). The 
wells were coated with human extracellular matrix at 10 µg in 150 µL HBSS per well 
(BD Biosciences, Franklin Lakes, NJ), and cured with UV light in a hood for 2 hours 
prior to seeding. The medium in the apical and basolateral chambers was 0.5 mL and 1.5 
mL, respectively. The cultures were maintained at 37°C in a humidified atmosphere of 
95% air/5% CO2. After 24 hours, the medium was replaced, and the cells were fed three 
times per week. The cells reached confluence in 2 to 3 days, but the TER continued to 
rise over the next 6 to 8 weeks. TER was monitored using an EVOM2 resistance meter 
with Endohm electrodes (World Precision Instruments, Sarasota, FL). Once the cultures 
were stable (6 weeks), they were adapted to SFM-1 over the course of 4 weeks before 
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conducting studies, as previously described by the Rizzolo lab [67]. SFM-1 consisted of 
70% Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/liter d-glucose, 
30% F12 nutrient mixture containing l-glutamine, and 1% antibiotic-antimycotic 
solution, supplemented with 2% B27 (Invitrogen, Carlsbad, CA). Throughout, cultures 
were maintained at 37°C in a humidified atmosphere of 95% air/5% CO2. 
Stem cell-derived RPE 
Human embryonic stem cell-derived RPE (hESC-RPE)!
Human embryonic stem cell-derived RPE was prepared by members of the 
Rizzolo lab from the H1 and H9 human embryonic stem cell lines (hESC-RPE) at the 
Yale Stem Cell Center, by the method of Idelson et al. [68]. Briefly, stem cells were 
cultured and passaged on Matrigel-coated dishes (BD Biosciences). Embryoid bodies 
were formed by treating undifferentiated stem cell colonies with 5 mg/ml dispase 
(StemCell Technologies, Vancouver, BC, Canada) and cultured as floating clusters in 
knockout serum replacement medium (KSR), composed of DMEM/F12 (1:1) medium, 
14% knockout serum replacement (Invitrogen), 1% nonessential amino acids (Sigma-
Aldrich, St. Louis, MO), 2 mM glutamine (Invitrogen), 50 U/ml penicillin, 50 µg/ml 
streptomycin (Invitrogen), and 10 mM nicotinamide (Sigma-Aldrich) in six-well ultra-
low-attachment cluster plates (Costar, Corning) for 1 week. The embryoid bodies were 
plated on laminin-coated culture dishes (10 µg/ml) for 6 weeks. During the third and 
fourth weeks, KSR was supplemented with 140 ng/ml actin A (Peprotech, Rocky Hill, 
NJ). After the sixth week, pigmented epithelial cells were isolated by trypsinization and 
seeded onto laminin-coated Transwell or Snapwell culture inserts (1.3 × 105 cells per 
well). Differentiated cells were expanded on laminin-coated dishes and purified by 
weeding unpigmented cells before reseeding on culture inserts. The reseeded cultures 
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were maintained in KSR for 6–8 weeks, when the cultures regained their pigmentation. In 
some cultures the KSR was then replaced with SFM-1, which had no effect on 
pigmentation, and the cultures were followed for an additional 4–5 weeks. 
Induced pluripotent stem cell-derived RPE (iPS-RPE) 
Induced pluripotent stem cell-derived RPE were prepared from induced 
pluripotent stem cells (iPS-RPE) of adult human RPE origin at a collaborating facility, 
The Neural Stem Cell Institute (NSCI; Rensselaer, NY), and were a generous gift from 
Drs. Tim Blenkinsop, Sally Temple, and colleagues at the NSCI. Maintenance and RPE 
cell culture were conducted per their published protocol [69]. Briefly, human adult RPE 
cells were reprogrammed as described previously [70]. qRT-PCR was used to confirm 
silencing of transgenes and expression of endogenous genes, and iPS cells were then 
differentiated in vitro into the three germ layers [70]. Pluripotency was demonstrated by 
comparing gene expression of iPS cells with that of reference standards. iPS cells were 
then dissociated using CTK solution and passaged 1:2 onto Matrigel-coated plates (BD 
Biosciences, San Diego, CA, http://www.bdbiosciences.com) in TeSR medium (Stem 
Cell Technologies, Vancouver, Canada, http://www.stemcell.com). 70-80% of confluent 
cells were then transferred to KSR medium supplemented with 500 ng/ml Noggin (R&D 
System) and 10µM SB431542 (Tocris, Bristol, U.K., http://www.tocris.com) every day 
for 3 days to drive neural induction. To further drive RPE differentiation, at day 5, 1mM 
nicotinamide (Sigma-Aldrich, St. Louis, MO) and 150 ng/ml ACTIVIN A (R&D Systems 
Inc., Minneapolis, MN) were added to the KSR as well [68]. RPE colonies were 
identified by their characteristic “cobblestone” morphology and pigmentation (which 
appeared at days 25-35), and manually picked and trypsinized. Colonies were then plated 
at 125 x 103 cells per well on a 24-well Primaria plate (BD Biosciences) in RPE-taurine, 
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hydrocortisone, triiodothyronine (THT) medium, as described previously [71]. Cells were 
trypsinized again after reaching confluency, and plated at 2 x 106 cells per T25 Primaria 
flask (BD Biosciences) in RPE-THT medium and grown to form an enriched RPE 
monolayer. Purified RPE cells were reseeded onto Transwell filters to obtain polarized 
confluent electrically stable RPE monolayers in approximately 6-8 weeks [69]. Once the 
iPS-derived RPE were confluent, epithelial morphology was confirmed using 
immunostaining, and gene expression analysis demonstrated expression of RPE markers 
(e.g., EZRIN, DCT). Transmission electron microscopy revealed typical RPE features in 
these cells such as cigar-and oval-shaped melanosomes located apically, tight junctions, 
and apical processes. Further, the iPS cell derived-RPE monolayer cultures maintained a 
physiologic TER and a steady-state intracellular calcium concentration [69]. Once stable, 
the iPS-derived RPE were generously gifted to the mentors’ laboratory on transwell 
filters. The cell cultures were maintained per this published protocol prior to use in 
studies.  
ARPE-19 
ARPE-19 cells were obtained from the American Type Culture Collection 
(passage 22; Manassas, VA). The cells were used at passage 22 and were initially 
maintained in tissue culture flasks for several weeks at 37oC in a humidified 5% CO2 
incubator in a medium of Dulbecco's Modified Eagle Medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Norcross, GA), 
2uM glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin, 1x pyruvate, 25mg/ml 
plasmocin (InvivoGen, San Diego, CA) until they were post-confluent. Then the cells 
were harvested and cultured at a density of 1.8 x 105 in a low serum medium comprised 
of basal DMEM with 1% FBS, 2uM L-glutamine, 100 U/ml penicillin and 0.1 mg/ml 
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streptomycin, 1x pyruvate, an insulin-transferrin-selenium-BSA–linoleic acid mixture 
(ITS+; BD Biosciences, Bedford, MA), and 25mg/ml plasmocin on laminin-coated clear 
filters (Transwell; Life science). This medium yielded cultures with native morphology, 
as demonstrated in earlier studies from the lab [64]. The cultures rapidly became 
confluent. The culture media were changed bi-weekly until the culture cells were ready to 
use (4-5 weeks post-confluency). 
Adult donor RPE 
The adRPE cells were supplied by the laboratory of Dr. Sally Temple (Neural 
Stem Cell Institute, Rensselaer, NY) and were prepared and maintained by that laboratory 
protocol [61]. The group at NSCI prepared the adRPE with a primary focus on extracting 
RPE in “sheets” in order to preserve the junctional bonds; if done in this way, the wells 
grow to an epithelial monolayer after 1 month in culture [61]. Post-confluency, the 
Temple lab at NSCI provided the adult donor RPE cells to the Rizzolo lab on individual 
transwell filters that were maintained in DMEM/F12 media supplemented with high 
glucose, MEM Alpha (Sigma-Aldrich, St. Louis, MO), 1% Penicillin/streptomycin, N1 
supplement (Sigma-Aldrich) 2% fetal bovine serum, 10mM non-essential amino acids 
(Sigma-Aldrich), L-glutamine 2mM, Taurine 75mg, Hydrocortisone 6µg, and Triiodo-
thyronin 0.0039µg. After the adult RPE cell arrived in our laboratory, the cells were kept 
for a week in this “Basic Media” to stabilize before harvesting the cells for analysis. 
 
Quantitative Reverse Transcription-Polymerase Chain Reaction !!
Real-time qRT2-PCR was used to accurately quantify autophagy-related and 
maturation-related gene expression levels of the different RPE culture models. To capture 
autophagy-related and maturation-related gene expression on a larger scale, we used two 
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customized 96-well PCR Arrays that had primers dried in wells prior to the lab receiving 
them (Bio-Rad, Hercules, CA). The autophagy-specific PCR array was modeled after the 
Human Autophagy RT Profiler PCR Array (SA Biosciences), and originally included 86 
genes involved in autophagy, including those encoding constituents of autophagosomes, 
lysosomes, and regulators of the autophagy pathway. The original array also included 5 
“quality control” genes that ensured reliable PCR performance and RNA integrity, and 5 
housekeeping genes to serve as internal controls for each reaction set. After preliminary 
experiments, we ordered a new set of autophagy-specific PCR arrays that included a 
narrowed set of genes of particular interest for the RPE culture experiments, and could fit 
two RPE culture cDNA samples on each plate (Figure 9, left). The maturation-specific 
PCR array (Figure 9, right) was custom-designed based on previous work in the lab 
examining signature gene expression in H1- and H9-hESC-RPE. They found that SFM-1 
supports the maturation of hESC-RPE by altering gene expression of signature RPE 
genes towards hfRPE-like levels [47]. The signature RPE genes included on the PCR 
array include both the genes whose expression level changed with SFM-1 and those 
genes that were already expressed in hESC-RPE at hfRPE levels.  
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Figure 9. Maturation- and Autophagy-Specific qRT2-PCR Arrays. Customized arrays to 
quantify signature/maturation-related (left) and autophagy-related (right) gene expression 
profiles of RPE cultures. ACTB, B2M, GAPDH are housekeeping genes for internal control. 
PCR, RQ1, RQ2 are quality control genes. **Only one side of each PCR array is shown—the 
second half of each is identical, so two RPE samples can be run on each array.** 
 
Briefly, baseline autophagy- and maturation-related gene expression of the 
different RPE cultures was examined using qRT2-PCR and RNA reverse-transcribing as 
follows. Total RNA was isolated by following the protocol included in the RNeasy Mini 
Kit (Qiagen, Valencia, CA). One microgram of total RNA was reverse-transcribed to 
cDNA using the Quantitect Reverse Transcription Kit (Qiagen, Valencia, CA). Two RPE 
cultures were run on each PCR array (one on each side), and real-time qRT2-PCR was 
used (iQ SYBR Green SuperMix, Bio-Rad CFX 96 thermal cycler; Bio-Rad, Hercules, 
CA). Experiments were performed with a minimum of two biological repeats. Relative 
expression of mRNA was calculated using the established 2−ΔΔCT method [72]. Briefly, 
the data were first normalized relative to the expression of three housekeeping genes 
(GAPDH, ACTB, B2M) and then relative to the expression of a reference mRNA (e.g., 
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hfRPE control cells). Error bars were calculated from independent experiments. Data is 
represented as the mean relative difference %± %SEM of the n separate qPCR amplification 
reactions. Because the primers are pre-dried in the array wells, the lab is only given the 
amplicon context for each primer. Using the accompanying software (Bio-Rad), PCR 
reaction efficiency was determined for each primer, and all primers used had efficiencies 
>95%. 
  
Protein Electrophoresis and Immunoblotting !!
Autophagic flux was determined to establish autophagic function of RPE culture 
models at baseline (i.e., control) and after treatment with an autophagy modulator or 
exposure to POS. Immunoblotting of LC3-II conversion is one method to confirm an 
increase in autophagy (Figure 5,6). LC3-I is converted to LC3-II upon association with 
autophagosomes, suggesting that an increase in the ratio of LC3-II:LC3-I is indicative of 
augmented autophagic flux [73]. Vice-versa, in dysfunctional autophagy, an absence of 
this conversion would be associated with a decreased ratio. These assays are performed in 
the presence of a lysosomal inhibitor to prevent the LC3-II from being degraded. Cultures 
were solubilized and prepared for immunoblotting, as described by the lab previously 
[74]. Briefly, the cultured RPE samples were washed with cold PBS and solubilized on 
ice in 200 µL of 25 mM Tris buffer (pH 8.0) containing 2% sodium dodecyl sulfate and 
10 µL/mL protease inhibitor cocktail (Sigma-Aldrich). Melanin granules were removed 
by centrifugation. Detergent-resistant protein multimers were prevented from forming by 
adding EDTA to 5 mM along with 50 µL of 5× gel loading buffer. The samples were 
incubated for 10 minutes at 37°C and then for 5 minutes in a boiling water bath. Protein 
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concentration was determined by using the NanoDrop Lite (Thermo Scientific, Rockford, 
IL). Equal amounts of protein were resolved by sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis and followed by immunoblotting. The level of β-actin staining was 
used as an internal standard to normalize each sample. The following primary antibodies 
from Cell Signaling (Danvers, MA) were used (dilutions in parentheses): rabbit 
polyclonal anti-LC3B (1:1000), rabbit polyclonal anti-Beclin-1 (1:1000), and rabbit 
monoclonal anti-PI3 Kinase class III (1:1000). Mouse monoclonal anti-rhodopsin 
(1:5000) was obtained from Novus Biologicals (Littleton, CO). Mouse monoclonal anti-
α-tubulin (1:1,500) was obtained from Invitrogen (Grand Island, NY). The immunoblots 
were developed using horseradish peroxidase-conjugated secondary antibodies (1:3,000) 
(Thermo Scientific, Rockford, IL) and SuperSignal West Femto reagent (Thermo 
Scientific, Rockford, IL) and were imaged and quantified!using ChemiDocTM MP 
imaging system and Image LabTM software version 4.1(Bio-Rad, Hercules, CA). 
 
Treatment with Autophagy Modulators !!
Stocks of the mTOR inhibitor, Rapamycin (Cell Signaling, Danvers, MA) were 
prepared in dimethyl sulfoxide (DMSO) and used as an autophagy stimulator in the cell 
culture. If indicated, RPE cell cultures were treated with 100nM Rapamycin for two 
hours before the cells were harvested for immunoblotting. Spautin-1 (Cellagen 
Technology, Cat # C3430-2s) was also dissolved in DMSO for storage, and was used as 
an autophagy inhibitor at a concentration of 10µM for 24 hours. To prevent degradation 
of LC3, the lysosomal inhibitor Chloroquine 80ug/ml (Sigma-Aldrich, St. Louis, MO) 
was added to RPE cultures 2 hours before the cells were harvested. 
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Analysis of POS Phagocytosis by RPE Cells in Culture !!
Phagocytosis assays will ensure that the various RPE cell lines have ingested the 
presented POS. Standard phagocytosis assays involve presenting fluorescently labeled 
POS to monolayers of RPE cells, and then observing the POS bound to cell surfaces or 
internalized within the RPE cell itself. Chronic exposure to POS would result in the 
formation of lipofuscin if the autophagic capacity of the cells were exceeded. Porcine 
POS were fed cultures once every 24 hours (daily, around 8:30am) to simulate the daily 
pattern of disc shedding that occurs in vivo. Cultures will be monitored daily by 
immunofluorescence to determine the time course for the formation of lipofuscin. For 
ARPE-19, this process has been shown to take about 1 week [22].  
Isolation of POS from Porcine Eyes 
We performed POS extraction from 180 porcine eyes (obtained from the local 
slaughterhouse), following the published protocol from Mao and Finnemann [75]. We 
obtained 180 pig eyes and processed them immediately upon arrival, keeping all 
materials ice-cold at all times. To start, we dissected the pig eyes one by one under dim 
light by using a scalpel to cut into the anterior segment of the eyeball, releasing the lens 
and vitreous fluid. The eyeball was then flipped inside out, and a fine pair of tweezers 
was used to delicately dislodge the retina from the underlying tapetum. The retina was 
collected in a 50 mL plastic tube containing 15 mL of a Homogenization solution (for 40 
mL: 20% sucrose, 20 mM Tris/Acetate pH 7.2, 2 mM MgCl2, 10 mM glucose, 5 mM 
taurine) on ice. We continued this process until all 180 retinas were collected in three 
separate 50 mL tubes. Next, we shook each suspension gently for 2 minutes, and then 
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filtered them individually three times through a layer of sterile gauze. Under a dim light, 
we used a 10 mL plastic pipet to add equal volumes of the crude retina isolate to six 30 
mL ultracentrifuge tubes that contained 25 mL of prepared solution of 60% sucrose, 20 
mM Tris/Acetate pH 7.2, 10 mM glucose, 5 mM taurine. The tubes were then spun in an 
ultracentrifuge rotor at 25,000 rpm (Beckman SW-28 rotor) for 48 minutes at 4° C. The 
upper third of the gradient (single pink band) was collected and diluted with 5 volumes of 
an ice-cold wash, consisting of 20 mM Tris-Acetate pH 7.2, 5 mM taurine (per 100 mL). 
The diluted solution was separated into 30 mL tubes and spun for 10 minutes at 3,000 x 
g. The supernatant was removed, and the pellet was resuspended in 10 mL of a second 
wash (for 50 mL: 10% sucrose, 20 mM Tris-Acetate pH 7.2, 5 mM taurine). The pellets 
were combined and spun for 10 min at 3,000 x g. The supernatant was removed and the 
pellet was resuspended in 45 mL of a third wash (for 100 mL: 10% sucrose, 20 mM 
phosphate buffer pH 7.2, 5 mM taurine) and spun for 10 min at 3000 x g.  
 To prepare the POS for storage, we divided the total amount into two volumes for 
1) unlabeled POS stock, and 2) FITC-labeled POS stock. The unlabeled POS stock was 
prepared by removing the supernatant of the halved volume, and resuspending the POS in 
10 mL 2.5% sucrose in DMEM. This was diluted to 1/50 in DMEM, and then the diluted 
POS were counted in a cell counting chamber. The yield and concentration were 
calculated, and then the POS was diluted to 1 x 108 POS/mL with 2.5% sucrose in 
DMEM. The POS was stored at -80° C in aliquots of 1 mL. To prepare the FITC-labeled 
POS stock, the other half of the total volume was resuspended in 5 mL of the third wash 
(for 100 mL: 10% sucrose, 20 mM phosphate buffer pH 7.2, 5 mM taurine), and 1.5 mL 
of FITC stock solution was added. This was rotated at room temperature for 1 hour in the 
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dark. The labeled POS was then washed twice with the third wash, twice in 2.5% sucrose 
in DMEM, and then resuspended in 2.5% sucrose in DMEM. The labeled POS was 
counted and stored as described for the unlabeled POS stock.  
 In the original dissection, using the hemocytometer, we counted an average of 43 
POS in .25 nl (i.e., one of the smallest squares). This was equivalent to 1.7 x 108 
POS/mL. For each RPE cell filter, we estimated that if cells were plated at 1 x 105 
cells/filter, confluency would be reached after a doubling (or possibly, tripling) of cells, 
making the total cells per filter equal to 2 x 105 (or 3 x 105). Generally, RPE cells are fed 
at 10 POS/RPE cell, so, we estimated that we would need about 12!µL of the POS 
solution per filter for a doubling of RPE cells, and about 20 µL of the POS solution per 
filter for a tripling of RPE cells. We ended up with ten 1 mL tubes of POS that were 
stored at -80°, and removed 1 mL tube at a time as needed for experiments. Each 1 mL 
tube was aliquotted into 20 400 µL eppendorf tubes (50 µL POS solution in each). Thus, 
each small eppendorf tube could feed about 3 RPE filters (15 µL/filter).    
Fluorescence Microscopy of RPE Cultures (Control and POS-Fed) 
RPE cultures were fed FITC-POS to the apical chamber for varying time periods 
between 3 hours and 24 hours. Additionally, RPE cultures were fed unlabeled POS to the 
apical chamber for varying time periods between 24 hours and 1 month (daily feedings). 
For feeding, RPE cells were fed 10 POS/RPE cell, which was 15 µL of POS solution (see 
previous section) per filter. For each feeding, the necessary number of POS-containing 
eppendorf tubes were thawed, and then spun down at 10,000 RPM for 2 minutes. The 
supernatant was removed under the cell culture hood, and the POS pellet was then 
washed with 1X PBS two times. The POS was then resuspended in 50 µL of DMEM and 
15 µL of POS was fed to the apical side of each well. 
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To visualize POS, we could observe the FITC-POS in live RPE cells under a 
fluorescence microscope. FITC-POS could be seen on a high magnification as green dots 
within the RPE cells. Additionally, we could use fluorescence microscopy to visualize 
FITC-POS both intracellularly and attached to the RPE cell membrane. RPE cells were 
fed FITC-POS for varying time periods (3 hours to 24 hours) before termination of 
phagocytosis. Phagocytosis was terminated by washing 3 times with PBS-CM. Cells 
were fixed with 4% PFA in PBS-CM for 20 min, and the remaining fixative was 
quenched by incubating cells in 50 mM NH4Cl in PBS-CM for 20 min. Filters were 
washed three times with 1X PBS for 10 minutes each. Filters were then cut out of their 
wells and cut into halves/thirds/quarters (depending on number of conditions needed for 
fluorescence). Cells were then blocked with 1% BSA in 1X PBS-CM for 20 minutes. 
Cells were incubated with mouse monoclonal anti-rhodopsin antibody (1:1000) from 
Novus Biologicals (Littleton, CO), diluted in 1% BSA in PBS for 25 min. Some 
experiments also included incubation of cells with mouse anti-occludin (1:200) or mouse 
anti-ZO-1 (1:400) (Invitrogen). Filters were then washed 2 times with PBS and 1 time 
with 1% BSA in PBS for 5 min each. Cells were then incubated with an appropriate 
secondary antibody that did not conflict with FITC; for example, for rhodopsin, either 
Cy3 or Cy5 dyes (1:200) (Jackson Immunoresearch Laboratories, West Grove, PA). 
Filters were washed 2 times with PBS for 5 min each, 1 time with DAPI nuclei stain for 
10 min, and 1 time with PBS for 5 min. Coverslips were mounted over filter pieces on 
microscopy slides with Cytoseal (Thermo-Scientific, Waltham, MA). FITC- and 
secondary antibody-derived fluorescence signals were imaged. Fluorescence images were 
acquired with an LSM 410 spinning-disc confocal microscope and processed using 
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AxioVision software (Carl Zeiss, Thornwood, NY). Internalized POS appeared in the 
FITC channel only. Surface-bound POS appeared both in the FITC channel and in the 
rhodopsin-specific secondary antibody image (e.g., Cy3 as red). In a color overlay of 
FITC (green) with secondary antibody (red), internal POS appeared green and surface-
bound POS appeared yellow.  
 
Ethical Considerations !
The Mentors’ lab obtains its hfRPE from the lab of Sheldon Miller at the National 
Eye Institute.  Miller’s protocols adhere to NIH Institutional Review Board guidelines, as 
well as the Declaration of Helsinki. One outcome of these studies may be to limit the 
need for tissue obtained from this controversial source.  
Similarly, the use of hESC-derived RPE prompts moral concerns. The WA01 and 
WA09 (H1 and H9, respectively) hESC lines used in the Mentors’ preliminary data and 
in the conducted studies are listed in the NIH hESC Registry and are approved for NIH 
funded research. The research was conducted under Yale ESCRO approval (project # E-
09-043) for Dr. Rizzolo.  
The use of adult donor RPE tissue is also associated with inherent ethical concerns. 
As with any donated tissue, established protocols were adhered to in order to ensure 
informed donor consent and proper storage and maintenance of RPE tissue. The adult 
donor RPE used in this project were obtained from the NSCI.  
These ethical aspects were considered thoroughly in the construction and completion 
of this project. Experiments were conducted with the utmost of respect for established 
protocols of tissue acquisition. Furthermore, these studies have helped pave the way for 
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additional research on other potential sources of RPE as suitable culture models, 
including iPS-RPE and umbilical cord derived stem cell RPE.   
 
RESULTS !
Baseline Autophagic Flux Varies by RPE Culture “Age” !
Autophagic flux was measured by immunoblotting LC3-I conversion to its 
lipidated form, LC3-II. Figure 10 demonstrates autophagic flux (LC3-II:LC3-I ratio) by 
RPE “age” (i.e., age of the RPE culture source) in blue. These assays are performed in the 
presence of a lysosomal inhibitor (Chloroquine) to prevent LC3 from being degraded, 
which allows measurement of amount of LC3-II (yellow), in addition to just flux. The 
LC3-II is normalized to β-Actin to allow comparison of relative amounts between the 
different RPE cultures. Although autophagic flux is the most commonly used marker of 
autophagic capacity, we felt it pertinent to also illustrate the relative amounts of LC3-II 
because there were noticeable differences in immunoblot band intensities, even after 
correcting for β-Actin (Figures 11,12). 
 Figure 10 demonstrates a gradual increase in autophagic flux from iPS-RPE and 
hfRPE cultures to a peak 78 year-old adult donor RPE. With the exception of 83 year-old 
adult RPE, autophagic flux then declined in the most aged RPE (to a low at 91 year-old 
RPE). LC3-II amounts were more variable, with the highest LC3-II amount seen in 
ARPE-19.   !
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Spautin-1 (SP-1) Partially Inhibits Autophagy in hfRPE, iPS-RPE, and Adult RPE !
Figures 11 and 12 illustrate immunoblotting of RPE cultures compared at baseline 
and after 24-hour treatment with the autophagy inhibitor SP-1 (10µM), which targets 
Beclin-1 in the canonical autophagy pathway. First, there is noticeable variability in the 
intensity of LC3-II bands between different RPE culture models, even when accounting 
for relative β-Actin. Second, the ability of SP-1 to inhibit autophagic flux (LC3-I to LC3-
II conversion) is not uniform across RPE cultures. 91 year-old adult RPE was the only 
other culture besides ARPE-19 where SP-1 strongly inhibited autophagy. Chloroquine 
was used to prevent degradation of LC3-II for immunoblotting. Additionally, Rapamycin 
(mTOR inhibitor) had little stimulatory effect on autophagy in RPE culture models, with 
the exception of hfRPE (not shown). 
Figure 10. Autophagic Flux (LC3-II:LC3-I) and LC3-II Amount by RPE “Age.” 
Autophagic flux increased from “immature” fetal and iPS-RPE to a peak in 78 year-old 
adult RPE, but declined in the most aged RPE. LC3-II was highest in ARPE-19. Error 
bars represent SEM for three independent experiments (n=3). LC3-II normalized to Actin. 
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We can dampen Spautin’s inhibitory effect by feeding 91 year-old adult RPE POS. By 
itself, POS stimulates autophagy in 91 year-old adult RPE.  !
!
  
These immunoblot findings of 91 year-old adult RPE (Figure 10-12), raised the 
question: How will the 91 year-old RPE respond to POS feeding, given their low 
autophagic flux and SP-1 sensitivity? Figure 13 demonstrates 91 year-old adult RPE at 
Figure 11. Spautin-1 (SP-1) Treatment. SP-1 
(10µM, 24hr) only partially inhibits autophagy (LC3-I 
to LC3-II conversion) in iPS-RPE and hfRPE, as seen 
by little change between control (“-“) and treatment 
(“+”). SP-1 strongly inhibits autophagy in ARPE-19, 
seen as decreased LC3-1 to LC3-II conversion with 
SP-1. Note the decreased intensity of the LC3-II band 
in iPS- and hfRPE, compared to ARPE-19. 
Figure 12. Spautin-1 (SP-1) Treatment of Adult RPE. SP-1 (10µM, 24 hr) only partially 
inhibits autophagy (LC3-I to LC3-II conversion) in almost all adult donor RPE cultures, as 
seen by little change between control (“-“) and treatment (“+”), with the exception of 91 year-
old adult RPE. Similar to its strong inhibitory effect in ARPE-19, SP-1 strongly inhibits 
autophagy in 91 year-old RPE, seen by decreased LC3-II:LC3-I ratio. *Note the variability in 
intensity of LC3-II bands. 
Figure 13. Effect of POS and Spautin-1 (SP-1) on 91 Year-Old 
Adult RPE. SP-1 treatment (10µM, 24 hr.) strongly inhibits 
autophagic flux (LC3-I to LC3-II conversion) in 91 year-old adult 
RPE (red box). POS exposure increased 91 yr. old RPE autophagic 
flux (yellow), and lessened the inhibitory effect of Spautin-1 (blue). 
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baseline (i.e., control), and after treatment with (from left to right): SP-1 (10µM), 3 hours 
POS only, SP-1 (10µM) and 3 hours of POS, and 3 days of POS only. Here, we can 
confirm SP-1’s strong inhibitory effect on autophagic flux in 91 year-old adult RPE. 
However, if 91 year-old RPE were fed POS for the last 3 hours of a 24 hour SP-1 
treatment, the inhibitory effect of SP-1 was dampened. Furthermore,  if fed POS alone 
(without SP-1 treatment), 91 year-old RPE had an increased autophagic flux, . 
After 3 days of POS, qRT2-PCR of autophagy genes showed 91 year-old RPE 
downregulated the expression of Beclin-1 (the driver of canonical autophagy, and target 
of SP-1) and genes involved in the formation of a phagophore (ATG5, ATG7). ATG3, a 
gene involved in the formation of an autophagosome, was upregulated (Figure 14).  
!!!
Relative iPS-RPE expression of RPE signature- and maturation-related genes most 
resembled that of human fetal RPE.  !
qRT2-PCR using a PCR array specific for maturation- and signature-related RPE 
genes allowed comparison of signature RPE gene expression of the various RPE culture 
models. Adult RPE (53 year-old and 91 year-old) demonstrated a unique maturation gene 
expression profile, with increased expression of a few signature genes relative to fetal 
RPE (not shown). One gene that was upregulated in adult RPE relative to fetal RPE was 
RPE65, which is involved in the visual cycle and is expressed by terminally differentiated 
Figure 14. 91 Year-old RPE 
Autophagy Gene Expression 
After POS. After 3 days POS, 
qRT2-PCR revealed 91 year-old 
adult RPE had downregulated 
gene expression of Beclin-1 and 
phagophore formation genes 
(ATG5, ATG7). The 
autophagosome formation gene 
ATG3 was upregulated. Gene 
expression is shown as fold-
change relative to control (n=2). 
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RPE. The gene for Transthyretin (TTR), which is apically secreted from RPE and 
involved in binding of retinoids, was also upregulated. 
PCR array also allowed comparison of the relative expression of signature RPE 
genes in the hypothetical “immature” RPE cultures, specifically hESC-RPE, iPS-RPE, 
and hfRPE. The lab has previously demonstrated signature RPE gene expression of 
hESC-RPE relative to fetal RPE in a growth medium and after transition to SFM-1 
medium (see Peng et al., 2013 for detailed review), and a similar maturation-related 
profile was seen in these repeat experiments of hESC-RPE in growth medium and SFM-1 
[47]. Additionally, RPE65 was downregulated in hESC-RPE relative to hfRPE. 
 To characterize iPS-RPE phenotypic age, we looked at expression of maturation 
and signature genes relative to fetal and hESC-derived RPE. Figure 15 shows fold change 
in gene expression (qRT2-PCR) of a narrowed number of pertinent signature genes in 
iPS-RPE relative to hfRPE. There were only two genes expressed at significantly 
different levels in iPS-RPE (derived from adult RPE tissue) relative to hfRPE: MMP-2 
and SLC24A3 were both downregulated (starred in Figure 15). MMP2 is the gene 
encoding the protein matrix metalloproteinase-2, which is implicated in pathologic RPE 
angiogenesis and cell migration. SLC24A3 encodes for solute carrier family 24 member 
3, a sodium/potassium/calcium exchanger. There was no significant difference in 
expression of the other 39 genes on the maturation-specific PCR array (Fig. 9, left).  
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Examining Baseline Autophagy-Related Gene Expression of RPE Culture Models !
 Having established that the maturation profile of iPS-RPE was most similar to 
fetal RPE, we next examined baseline autophagy-related gene expression profiles of the 
RPE culture models, using fetal RPE as the standard “control.” Figure 16 illustrates 
baseline normalized autophagy-related gene expression of adult donor RPE (53 year-old) 
relative to hfRPE. This adult donor RPE was the same 53 year-old adult RPE that had a 
high autophagic flux at baseline (Figure 10). Here, we show a narrowed spectrum of 
genes to focus on key players in autophagosome formation, phagophore formation, and 
autophagy modulation (i.e., Beclin-1, mTOR). At baseline, adult RPE had general 
increased expression of most autophagy-related genes relative to hfRPE. Genes that were 
expressed at levels of significant difference (p<.05) are indicated and written in Figure 
16. Of particular interest, 53 year-old adult RPE had significant upregulation of genes 
involved in autophagosome formation relative to hfRPE, including ATG3, ATG4, and 
Figure 15. qRT2-PCR of Signature Gene Expression in iPS-RPE. Expression of 
maturation and signature genes in iPS-RPE revealed only two genes of significant 
difference relative to hfRPE: MMP2 and SLC24A3 (p<.05). Error bars represent 
SEM for n=3. 
!! 39!
two members of the LC3 family, GABARAPL1 and MAP1LC3A. There was slight 
upregulation of mTOR and BECN1, around two-fold change, but this did not reach 
significance. ULK2, which encodes the protein Unc-51-like kinase 2, was also 
upregulated, near a four-fold change, but did not reach significance. ULK2 encodes a 
pro-autophagic protein that acts upstream of Beclin-1 and PI3 Kinase class III. 
 Having demonstrated an increase in expression of autophagosome formation 
genes in adult RPE, we next compared baseline autophagy-related gene expression of 
iPS-RPE relative to fetal RPE (Figure 17). Genes that were expressed at levels of 
significant difference (p<.05) are indicated in Figure 17. There was significant 
upregulation of autophagosome-formation genes ATG3, ATG4A, and MAP1LC3A. 
LAMP1, USP13 and ULK2 were upregulated, but did not reach significance. USP13 
encodes for the protein ubiquitin carboxyl-terminal hydrolase 13, which is involved in 
tumor suppression. USP13 also reduces levels of ubiquitinated Beclin-1 when 
overexpressed, thus promoting autophagy. 
 
 Figure 16. Baseline Autophagy-Related Gene Expression of Adult RPE. qRT
2-
PCR of autophagy-related gene expression of 53 year-old Adult RPE relative to 
16wk hfRPE. Error represents SEM, n=3. Genes of significant difference are written 
and indicated on the figure: ATG3, ATG4, GABARAPL1, MAP1LC3A (p<.05).   
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For figures illustrating fold change in gene expression (i.e., Figure 15, 16, 17, 19), 
it is important to note that some genes are expressed at large fold-changes that did not 
reach significance. This is a reflection of the fact that comparisons may look significant, 
but when copy number is very low, a large fold change may not reach significance. 
 
Examining the Effect of Photoreceptor Outer Segments (POS) on RPE “Age” !
 The native RPE is charged with phagocytosis and lysosomal degradation of POS 
that are shed from the overlying neural retina on a daily basis. Phagocytic overload and 
subsequent autophagic dysfunction can contribute to AMD pathogenesis in the aged RPE. 
However, in the short-term or in relatively “immature” RPE, the effect of POS is less 
clear. Fetal RPE and hESC-RPE have been shown to have the ability to phagocytize POS, 
even though neither has seen POS at their ages (16 week and 13 week gestation, 
Figure 17. Baseline Autophagy-Related Gene Expression of iPS-RPE. qRT2-PCR 
of autophagy gene expression of iPS-RPE (derived from adult human RPE tissue) 
relative to 16wk fetal RPE. Like adult donor RPE, iPS-RPE had increased expression 
of autophagosome genes. Genes of significant difference are written on the figure: 
ATG3, ATG4A, MAP1LC3A. (p<.05). Error represents SEM, n=3. 
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respectively) in vivo. In “young” RPE that do not yet have a need for increased autophagy 
to handle damaged organelles and proteins, how will POS effect autophagy and 
phenotypic age in vitro? 
 First, to confirm phagocytic uptake of POS by hfRPE, hESC-RPE, and iPS-RPE, 
we fed each immature RPE FITC-labeled POS for 1 to 24 hours. Figure 18 provides a 
representative depiction of FITC-POS phagocytosis. Figure 18 demonstrates iPS-RPE 
uptake after 12 hours FITC-POS feeding, however similar uptake was observed in hfRPE 
and hESC-RPE. A 3-dimensional view of the RPE monolayer is shown, with FITC-
labeled POS appearing as green. The nucleus appears blue (DAPI), and the secondary 
antibody for rhodopsin appears red (Cy3). When visualizing, pure green at the level of 
DAPI is FITC-POS within the RPE cell, and green+red (yellow) is POS at the RPE apical 
membrane, either right before or during phagocytosis.  
 
Figure 18. RPE Phagocytosis of FITC-POS. Representative phagocytosis of POS by 
iPS-RPE (similar uptake seen in hfRPE and hESC-RPE). Blue (DAPI) is the nucleus (i.e., 
intracellular), Green (FITC) is POS within the cell, Red (Cy3) is rhodopsin, Green+Red is 
POS at the RPE apical membrane, either during or right before phagocytosis.  !
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To examine the effect of POS on hfRPE autophagy, we fed fetal RPE POS daily 
(10 POS/cell) for one week. Figure 19 illustrates the effect of 7 days POS treatment on 
autophagy-related gene expression in fetal RPE. Genes that were expressed at levels of 
significant difference (p<.05) are indicated in Figure 19 with a star. There was significant 
upregulation of the autophagosome formation genes ATG3 and LAMP1 at p<.05. The 
autophagosome gene ATG4A was upregulated at a level that trended toward, but did not 
reach, significance (p<.1). The phagophore formation genes ATG5 and ATG12 were also 
significantly upregulated (p<.05), as was the anti-apoptotic, pro-autophagic gene BCL2. 
The autophagosome formation-related LC3 family genes GABARAPL1, GABARAPL2, 
MAP1LC3A, and MAP1LC3B were upregulated, but did not reach significance. 
 
Figure 19. Autophagy-Related Gene Expression of Fetal RPE After 7 Days POS. 
qRT2-PCR of autophagy gene expression of 16wk hfRPE after 1 week of daily POS 
feeding, relative to control hfRPE. Autophagosome genes that were upregulated in iPS-
RPE and adult RPE at baseline were increased in fetal RPE after POS. (Significance*= 
p<.05) (Trend toward significance**=p<.1). Error bars represent SEM, n=3. !
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Thus, the autophagosome genes that were upregulated in iPS-RPE and adult RPE 
at baseline were now increased in fetal RPE after 7 days of POS exposure (Figure 18). 
Interestingly, in the immature hESC-RPE, although 2 days of POS resulted in a general 
increase in autophagy-related genes, autophagy gene expression returned to baseline by 7 
days (not shown). A similar finding was present in iPS-RPE, although they started at an 
adult-level autophagy gene expression. 
Figure 20 shows a confocal microscope image of the iPS-RPE monolayer after 
three weeks of daily, unlabeled POS feeding. The iPS-RPE is unstained and has an 
accumulation of intracellular granules. True autofluorescence is confirmed by the 
presence of these granules on the individual channels. This cut-view image is shown as a 
merge of Brightfield, Cy3, and GFP channels at 100X magnification.  
 
 
 
 
 
 
Figure 20. Accumulation of Autofluorescent Granules in iPS-RPE After 3 Weeks 
POS. Autofluorescent granules accumulated in iPS-RPE after 3 weeks of unlabeled 
POS feeds (10 POS/cell). TER was stable at physiologic levels, and iPS-RPE 
signature and autophagy-related gene expression was relatively unchanged from 
control. In this confocal image, RPE is unstained. Cut view image shows merge of 
Brightfield, Cy3, and GFP channels at 100X magnification. Large panel, xy plane; top 
ribbon, xz plane, right-side ribbon; yz plane. 
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DISCUSSION !
Conclusions 
 
Over 10 million people in the United States demonstrate AMD-related ocular 
changes, and more than 1.5 million American suffer from the advanced form of the 
disease. Given a globally aging population, a doubling of AMD patients is expected by 
2020 [1]. Unfortunately, current therapies serve only to delay disease progression, not 
restore sight. AMD is particularly devastating in that it impinges on daily activities, such 
as reading and recognizing faces. Accumulating evidence indicates that diminished 
autophagic flux may contribute to the etiology of the disease. Over the lifetime of an 
individual and the post-mitotic RPE, phagocytic overload can burden the autophagy 
pathway, resulting in accumulation of vesicles, cellular debris, and lipofuscin. 
Undegraded material is eventually extruded from the basolateral side of the RPE as 
drusen, a hallmark of AMD. The precise mechanisms by which phagocytosis and 
autophagy interact are not clear, and one goal of this project was to better understand the 
connection between the two intertwined pathways. This is the first study to the author’s 
knowledge that systematically evaluates the various RPE culture models and combines 
them to identify target genes and pathway points for future studies of pharmacological 
intervention. These studies will broaden the understanding and potential research 
applications of available culture models of RPE. By categorizing RPE models as 
phenotypically “young” or “aged” and studying them as such, one can explore the 
progression from healthy to diseased RPE (e.g., as occurs in AMD). 
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Autophagic “flux” is increasingly recognized as the preferred method to monitor 
autophagy, as it indicates progression from the autophagosome to the autophagosome-
lysosome fusion step, which is crucial to successful completion of autophagy. Conversion 
of LC3-I to its lipidated form LC3-II occurs at this fusion step, so flux is often illustrated 
by the ratio of LC3-II:LC3-I [73]. Thus, an increase in LC3-II:LC3-I is indicative of 
increased autophagic flux, whereas decreased autophagic flux (i.e., decreased ratio) can 
occur because of impaired autophagy and in cells (e.g., “young” hfRPE) that do not yet 
need a high rate of autophagic degradation and recycling. As expected, we found that 
autophagic flux varied between the available RPE culture models. Further, we found that 
autophagic flux varied by RPE phenotypic “age.” Specifically, autophagic capacity 
increased from “immature” fetal- and iPS-derived RPE, throughout middle aged adult 
RPE, and peaked in 78 year-old adult RPE. Flux then declined in the most aged RPE 
cultures, with the lowest LC3-II:LC3-I ratio for adult RPE seen in 91 year-old RPE. 
These findings are similar to studies of autophagy in other cell types and diseases. At 16 
weeks gestation, fetal RPE have not yet been exposed to POS or experienced chronic 
oxidative stress, and accordingly do not need a high level of autophagy to degrade and 
recycle damaged organelles, misfolded proteins, or visual cycle components. However, 
over the lifetime of an individual, oxidative stress and daily POS phagocytosis can impair 
the ability of the post-mitotic RPE to perform autophagy. This is reflected in the decline 
in autophagic flux seen in the aged RPE cultures.  
We also measured the amount of LC3-II (immunoblot) present in each RPE 
culture. LC3-I is converted to LC3-II upon association with an autophagosome. Studies 
have increasingly recognized that LC3-II alone is not sufficient to measure ongoing 
!! 46!
autophagy. Rather than indicating successful autophagosome-lysosome fusion, increased 
LC3-II could instead indicate an accumulation of autophagosomes and unsuccessful 
completion of autophagy [60]. Interestingly, we found that LC3-II varied between 
different RPE cultures without any clear pattern. Of note, ARPE-19 had the highest 
amount of LC3-II at baseline, but not the highest flux. This suggests that there is 
accumulation of autophagosomes and impaired turnover of LC3-II, which may indicate 
dysfunctional autophagy in ARPE-19. This supports previous studies’ findings that 
ARPE-19 is more appropriate as a model of diseased or aged RPE.  
ARPE-19 was also unique in its response to the autophagy inhibitor Spautin-1, 
which targets Beclin-1 in the canonical autophagy pathway. Previous work by Dr. Haben 
Kefella (YSM 2014) confirmed near-complete inhibition of autophagic flux in ARPE-19 
by 24 hour SP-1 treatment (10 µM). However, SP-1 only partially inhibited autophagy in 
hfRPE, iPS-RPE, and almost all adult RPE cultures. Surprisingly, 91 year-old RPE (the 
most aged RPE) was the only other culture where SP-1 strongly inhibited autophagy. 
However, we found that we could dampen SP-1’s inhibitory effect by feeding 91 year-old 
RPE POS. Additionally, by itself, feeding POS stimulated autophagy in 91 year-old RPE, 
suggesting that phagocytosis of POS led to a downstream stimulation of autophagy.  
In conclusion, SP-1’s partial inhibition of autophagy in most RPE cultures 
suggests the presence of a non-canonical autophagy pathway that bypasses Beclin-1. 
These findings also suggest that this non-canonical pathway can be re-activated (e.g., 
with short-term POS feeding) in very aged (or diseased) RPE to increase autophagic 
capacity. However, the target for stimulation of this pathway is likely not Rapamycin, 
which has been proposed as a therapy for AMD in the past, given its potential as a 
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therapy for other neurodegenerative diseases such as Alzheimer’s. We found that 
Rapamycin had little stimulatory effect on RPE cultures (with the exception of hfRPE), 
suggestive of a non-canonical autophagy pathway that is not regulated through mTOR. In 
fact, recently published results of phase I/II clinical trials of intravitreal and 
subconjunctival Rapamycin as a therapy for geographic atrophy reported that no positive 
anatomic or functional effects were identified, and that Rapamycin may be associated 
with effects that are actually detrimental to visual acuity [76, 77].  
These findings inspired a return to the literature for other reports of a non-
canonical autophagy pathway in RPE. As discussed, previous studies have provided 
evidence for a Beclin1-independent (i.e., non-canonical) autophagy pathway in cancer 
cell lines and infection [35-38]. In July 2013, Kim et al. reported a non-canonical form of 
autophagy in RPE (referred to as LC3-associated phagocytosis) that is involved in visual 
component regeneration through POS phagocytosis [78]. In RPE-J cells, they noted 
association of LC3 with single membrane phagosomes that contained phagocytized POS. 
This form of non-canonical autophagy was different than that previously reported and the 
author’s findings, in the sense that it was Beclin1-dependent. Regardless, it provides 
additional support for the existence of alternative autophagy pathways in LC3, and 
illustrates a direct connection between the phagocytic and autophagic pathways. In 
contrast to Kim et al.’s finding that non-canonical autophagy depended on Beclin-1 and 
gene products involved in phagophore formation (specifically, Atg5), our results suggest 
the presence of a non-canonical, Beclin1-independent pathway that is unaffected by SP-1. 
Analysis of baseline autophagy-related gene expression suggests that adult RPE 
cultures with high baseline autophagic flux had increased expression of key 
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autophagosome-forming genes (i.e., ATG3, ATG4A, GABARAPL1, and MAP1LC3), 
and downregulated or unchanged levels of phagophore-related genes (such as ATG5, 
ATG7, BECN1). These same autophagosome genes were upregulated in 91 year-old 
adult RPE and hfRPE after 3 days and 1 week of POS, respectively. Thus, phagocytized 
POS appear to merge with the autophagy pathway after the Beclin1-dependent 
phagophore formation step. Additionally, this demonstrates that autophagic function of 
“immature” fetal RPE and “aged” or diseased adult RPE can be pushed toward a healthy 
adult-like state by exposure to POS.  
Figure 21 is a revised illustration of the canonical and non-canonical autophagy 
pathway, based on the results of this project. Canonical autophagy is shown as a Beclin1-
dependent pathway, stimulated by Rapamycin and inhibited by SP-1. Here, we 
demonstrate the entry of phagocytized POS into the non-canonical autophagy, 
specifically at the point of the autophagosome. Our results suggest that genes involved in 
autophagosome formation are key to autophagic capacity, particularly in the aging RPE 
or when exposed to POS. Phagophore genes were largely unchanged or downregulated. 
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Figure 21. Canonical and Non-canonical Autophagy Pathways Revised. Canonical 
autophagy is Beclin1-dependent, inhibited by Spautin-1, and stimulated by Rapamycin. 
Autophagosome formation genes are key to a non-canonical autophagy pathway, and are 
upregulated after POS phagocytosis, suggesting an alternative entry point for POS. 
(Illustration reproduced and modified with permission of Cell Signaling Technology, Inc. 
www.cellsignal.com). 
 
A secondary aim throughout this project was to characterize the maturation-
related and autophagy-related gene expression profiles of iPS-RPE cell cultures. As stem 
cell-derived cells, iPS-RPE have been considered “immature,” and are expected to lie on 
the “young” end of the phenotypic age spectrum in Figure 9. The iPS-RPE used in these 
experiments were derived from adult human RPE tissue, thus their gene expression 
profiles are not as well characterized as iPS-RPE derived from adult fibroblasts, which 
constitute the majority of previous studies on iPS-RPE [50, 57, 69, 79, 80]. PCR array of 
signature genes revealed that the maturation expression profile of iPS-RPE most 
resembled that of fetal RPE, supporting its relative immaturity. Considering this, it was 
surprising to find that iPS-RPE express autophagy-related genes (in particular, 
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autophagosome-formation genes) at adult RPE levels (Figure 17). This raises the 
question: do iPS derived from human adult RPE retain epigenetic markers? Future studies 
will help to address this issue. Interestingly, after three weeks of unlabeled POS feeding, 
accumulation of autofluorescent granules was observed in iPS-RPE. Transepithelial 
resistance (TER) remained stable at physiologic levels, and iPS-RPE signature and 
autophagy-related gene expression were relatively unchanged from control. Of note, 
previous studies demonstrate an accumulation of autofluorescent material in ARPE-19 
after just 1 week of POS feeding [22]. I propose that iPS-RPE derived from adult RPE 
tissue have great potential as a novel source of cells for RPE transplantation therapy due 
to their relatively “young” phenotypic age combined with adult-like autophagic 
capabilities and prolonged stability in the presence of lipofuscin. 
Figure 22 offers a revised hypothesis of phenotypic age among RPE cultures 
based on this project’s results, which suggest that the most “immature” RPE culture is 
hESC-RPE. Unlike fetal RPE, POS feeding had no effect on the autophagy or maturation 
expression profiles of hESC-RPE, indicating that this RPE culture model has not 
developed the signaling pathways to connect phagocytosis and autophagy. Thus, hESC-
RPE may not be an appropriate culture model to study AMD pathogenesis because its 
autophagy pathway cannot be manipulated to induce phenotypic aging. In contrast, RPE 
derived from 16-week human fetuses did have the necessary signaling pathways in place, 
resulting in maturation toward an adult-like autophagic state after POS exposure. This 
suggests that hfRPE are primed for POS exposure, which first occurs in utero at 19-20 
weeks gestation. Based on signature gene expression, iPS-RPE is relatively “immature,” 
similar to fetal RPE. However, at baseline, iPS-RPE that are derived from adult RPE 
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tissue have increased autophagy-related gene expression, similar to the autophagy 
expression profile of an adult. Specifically, genes involved in autophagosome formation 
are upregulated in iPS-RPE and 53 year-old adult RPE. With long term POS, iPS-RPE 
autophagy gene expression is relatively unchanged, though it is already at adult levels.  
 
Adult RPE demonstrated a peak in autophagic flux and generally high levels of 
autophagy-related gene expression relative to other RPE culture models. With each 
decade past 50 years-old, however, autophagic flux began to plateau and then declined in 
the most aged RPE cultures, to a nadir at 91 year-old RPE. Feeding 91 year-old RPE POS 
for a short period did increase autophagic capacity, however it is unsure if that is 
sustainable over longer feeding periods. It is important to consider that this is a limited 
sample size, and that there are inherent differences between the adult RPE cultures. 
Future studies will expand the sample size and include multiple adult RPE cultures of the 
same age to account for this inherent variability.  
Lastly, ARPE-19 was distinct as a RPE culture model that did not fit into a 
 
Figure 22. Phenotypic Age of Autophagy Pathway Revised. Since the RPE lasts the 
lifetime of an individual, RPE cultures can be placed along a phenotypic age spectrum based 
on autophagic capacity. From fetal life on, RPE autophagic capacity increased to peak levels 
in adult RPE, and was impaired in the most aged RPE. We could manipulate this age spectrum 
to increase autophagy in various culture models (e.g., by feeding hfRPE POS). ARPE-19 did 
not fit appropriately at any point on the phenotypic age spectrum, and is not included. 
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specific phenotypic age on this spectrum. Although ARPE-19 is a commonly used culture 
model for RPE studies, an emerging theme throughout this project was ARPE-19’s 
differing characteristics, morphology, and response to autophagy modulators compared to 
the other RPE culture models. Our results suggest that ARPE-19 is not an appropriate 
“healthy” model of native RPE, and this should be taken into account for future studies. 
Accordingly, ARPE-19 is not included in the revised Figure 22. 
A limitation of this study was that among the fetal and iPS-RPE, there are also 
inherent differences in the tissue samples. To ensure reliability of results, the highest 
quality cell line was used for the iPS-RPE experiments, and data was acquired from at 
least two biological repeats. Thus, over the course of this one-year project, there were 
times when I was only able to generate data from a limited sample size. Accordingly, the 
results from this study may be considered provisional, but will lay the foundation for a 
more complete study. 
 In conclusion, this project offered methodology to evaluate phenotypic age in 
available RPE cell lines, and, further, to induce aging in “immature” RPE models (e.g., 
hfRPE) via exposure to POS and autophagy manipulation. This project also provided a 
more thorough comparison of the autophagy- and maturation-related gene expression 
between the various available RPE cells, allowing quantitative analysis of the differences 
in expression capabilities between the lines. Additionally, this project offers a novel way 
to study AMD—specifically, investigating the disease in vitro as it develops and presents 
in vivo, i.e., throughout an individual’s lifetime, in an aged phenotype. This project has 
opened an avenue of study to identify target genes that can be manipulated in the 
autophagy pathway based on differences between phenotypically “young” and “aged” 
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RPE culture models. Candidate genes will be those that appear to be rate-limiting steps of 
the autophagic pathway. For future studies, siRNA will be used to knockdown candidate 
genes in “immature” RPE, and adenoviral vectors will be employed to exogenously 
express them in “aged” RPE. The ability of pharmaceuticals to regulate these genes and 
address the impaired pathway will then be tested. Such future studies will move this 
research into the realm of additional translational research, bringing the bench to the 
bedside and offering a chance for clinical improvement for those afflicted with AMD. 
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